Matthew Collin

Professor Matthew Collin is a leading academic at Newcastle University in the Institute of Cellular Medicine, focusing on dendritic cell biology, stem cell transplantation, and immunodeficiency disorders. His work bridges clinical research and translational immunology, with extensive collaborations across European transplant networks like EBMT.

• Key Research Themes:
• Dendritic cell ontogeny in hematopoietic stem cell transplantation
• Mechanisms of graft-versus-host disease (GvHD)
• Genetic basis of histiocytic disorders (e.g., Langerhans cell histiocytosis, Erdheim-Chester disease)
• Immune reconstitution post-transplantation

Publication Trends highlight his leadership in understanding myeloid lineage commitment, HLA-mismatched transplant risks, and biomarker development for GvHD. His recent 2024-2025 studies emphasize clinical trial design (MoTD trial) and molecular profiling of rare immune disorders.

Collaborative Network includes co-authors from Newcastle University, European Bone Marrow Transplantation (EBMT) working parties, and interdisciplinary teams in immunology, hematology, and infectious diseases. While scientific awards and student mentorship details are not explicitly stated here, his role in advancing clinical guidelines for histiocytosis is evident.